Institutional investors purchased a net $5.0 million shares of EXAS during the quarter ended September 2014 and now own 89.38% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 1.5 Million shares of Exact Sciences Corp
MASSACHUSETTS FINANCIAL SERVICES... Bought 1.3 Million shares of Exact Sciences Corp
CITIGROUP GLOBAL MARKETS INC. (B... Bought 891.3 Thousand shares of Exact Sciences Corp